ProfileGDS4718 / 205605_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 49% 52% 45% 51% 51% 41% 46% 55% 54% 47% 47% 44% 45% 46% 45% 47% 51% 45% 46% 52% 59% 48% 52% 50% 48% 40% 45% 45% 60% 45% 45% 46% 51% 49% 46% 46% 41% 50% 49% 47% 45% 45% 40% 44% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.4547149
GSM549102patient 115, normal, homogenized [OPG study]5.6777652
GSM549104patient 119, normal, homogenized [OPG study]5.2370945
GSM549108patient 138, normal, homogenized [OPG study]5.6301151
GSM549119patient 077, normal, homogenized [OPG study]5.5652451
GSM549133patient 032, cancer, homogenized [OPG study]5.0061641
GSM549139patient 042, cancer, homogenized [OPG study]5.2653746
GSM549099patient 107, normal, homogenized [OPG study]5.8256355
GSM549109patient 139, normal, homogenized [OPG study]5.7886454
GSM549110patient 046, normal, homogenized [OPG study]5.3682547
GSM549114patient 063, normal, homogenized [OPG study]5.3178547
GSM549122patient 082, normal, homogenized [OPG study]5.2229344
GSM549134patient 033, cancer, homogenized [OPG study]5.2194945
GSM549136patient 036, cancer, homogenized [OPG study]5.2591846
GSM549140patient 044, cancer, homogenized [OPG study]5.1811545
GSM549111patient 047, normal, homogenized [OPG study]5.3275847
GSM549113patient 057, normal, homogenized [OPG study]5.531151
GSM549132patient 031, cancer, homogenized [OPG study]5.2554545
GSM549137patient 038, cancer, homogenized [OPG study]5.2762446
GSM549142patient 047, cancer, homogenized [OPG study]5.7799952
GSM549100patient 110, normal, homogenized [OPG study]6.061559
GSM549107patient 135, normal, homogenized [OPG study]5.3750948
GSM549115patient 068, normal, homogenized [OPG study]5.5695252
GSM549116patient 072, normal, homogenized [OPG study]5.4921750
GSM549120patient 078, normal, homogenized [OPG study]5.3785348
GSM549131patient 030, cancer, homogenized [OPG study]4.9541140
GSM549118patient 074, normal, homogenized [OPG study]5.2334545
GSM549129patient 027, cancer, homogenized [OPG study]5.2808745
GSM549123patient 088, normal, homogenized [OPG study]6.1613560
GSM549124patient 006, cancer, homogenized [OPG study]5.2645745
GSM549126patient 015, cancer, homogenized [OPG study]5.2153545
GSM549128patient 025, cancer, homogenized [OPG study]5.2678946
GSM549103patient 117, normal, homogenized [OPG study]5.606651
GSM549117patient 073, normal, homogenized [OPG study]5.4275649
GSM549138patient 041, cancer, homogenized [OPG study]5.2734546
GSM549141patient 045, cancer, homogenized [OPG study]5.2256246
GSM549130patient 028, cancer, homogenized [OPG study]5.0623241
GSM549101patient 111, normal, homogenized [OPG study]5.5484750
GSM549105patient 128, normal, homogenized [OPG study]5.4749849
GSM549106patient 134, normal, homogenized [OPG study]5.3059347
GSM549112patient 048, normal, homogenized [OPG study]5.2497545
GSM549125patient 011, cancer, homogenized [OPG study]5.2622245
GSM549127patient 024, cancer, homogenized [OPG study]4.9674140
GSM549135patient 035, cancer, homogenized [OPG study]5.1694344